...
首页> 外文期刊>Annals of Clinical and Laboratory Science: Official Journal of the Association of Clinical Scientists >Perivascular epithelioid cell tumor (PEComa) of the urinary bladder associated with Xp11 translocation
【24h】

Perivascular epithelioid cell tumor (PEComa) of the urinary bladder associated with Xp11 translocation

机译:与Xp11移位相关的膀胱血管周上皮样细胞瘤(PEComa)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Perivascular epitheliod cell-containing tumors (PEComas) represent a rare family of neoplasms. Their dichotomous phenotypic features, including both myogenic and mylanocytic features, can make a definitive diagnosis difficult. Such tumors have been associated with the overexpression of transcription factor E3 (TFE3). An Xp11 translocation could account for the aberrant activity of TFE3 but has never before been described in affiliation with a PEComa of the urinary bladder. While PEComas of the bladder have exhibited benign clinical courses to date, here we present an intavesical PEComa shown to have an Xp11 translocation and resultant overexpression of TFE3, indicating an aggressive, metastatic nature. No consistent tumor characteristics have proven accurate at identifying aggressive tumors. However, mTOR inhibitors offer a mechanistic management strategy when systemic therapy is warranted.
机译:包含血管上皮细胞的肿瘤(PEComas)代表了罕见的肿瘤家族。它们的二分型表型特征(包括肌原性和黑素细胞特征)可能使确定的诊断变得困难。这种肿瘤与转录因子E3(TFE3)的过表达有关。 Xp11易位可能是TFE3异常活动的原因,但从未与膀胱PEComa关联。尽管迄今为止,膀胱PEComas表现出了良性的临床过程,但在这里,我们介绍了一个无内胎的PEComa,它被证明具有Xp11易位和导致TFE3的过度表达,表明具有侵略性,转移性。已证明没有一致的肿瘤特征可准确识别侵袭性肿瘤。但是,当需要全身治疗时,mTOR抑制剂可提供机械治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号